Misuse and Abuse of Loperamide in the United States

Study identification

• EU PAS number:
  EUPAS16778
• Study ID:
  32664
• Official title and acronym:
  Misuse and Abuse of Loperamide in the United States
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  This is a retrospective non-interventional study of secondary data sources to document the misuse and abuse of loperamide in the US. This study aims to characterize the abuse and misuse of loperamide in the US through the evaluation of two independent surveillance data systems. The objectives of this study are: 1) to describe abuse and misuse of loperamide as reported to the National Poison Data System (NPDS) and 2) to describe non-medical use of loperamide as reported via an online survey of Non-Medical Use of Prescription Drugs (NMU-Rx) by a general adult population sample.
• Study status:
  Finalised

Research institutions and networks

Institutions

Denver Health and Hospital Authority

Study timelines

Date when funding contract was signed

Planned:20/10/2016

Actual:20/10/2016

Study start date

Planned:20/12/2016

Actual:20/12/2016

Date of final study report

Planned:27/09/2019

Actual:30/06/2017

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Johnson & Johnson Consumer Inc.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable